Nitroglycerin use in myocardial infarction patients (2012)
- Authors:
- Autor USP: FERREIRA, JULIO CESAR BATISTA - ICB
- Unidade: ICB
- DOI: 10.1253/circj.CJ-11-1133
- Assunto: ANATOMIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Circulation Journal
- ISSN: 1347-4820
- Volume/Número/Paginação/Ano: v. 76, n.1, p.15-21, 2012
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
FERREIRA, Julio Cesar Batista e MOCHLY-ROSE, Daria. Nitroglycerin use in myocardial infarction patients. Circulation Journal, v. 76, n. 1, p. 15-21, 2012Tradução . . Disponível em: https://doi.org/10.1253/circj.CJ-11-1133. Acesso em: 25 abr. 2024. -
APA
Ferreira, J. C. B., & Mochly-Rose, D. (2012). Nitroglycerin use in myocardial infarction patients. Circulation Journal, 76( 1), 15-21. doi:10.1253/circj.CJ-11-1133 -
NLM
Ferreira JCB, Mochly-Rose D. Nitroglycerin use in myocardial infarction patients [Internet]. Circulation Journal. 2012 ; 76( 1): 15-21.[citado 2024 abr. 25 ] Available from: https://doi.org/10.1253/circj.CJ-11-1133 -
Vancouver
Ferreira JCB, Mochly-Rose D. Nitroglycerin use in myocardial infarction patients [Internet]. Circulation Journal. 2012 ; 76( 1): 15-21.[citado 2024 abr. 25 ] Available from: https://doi.org/10.1253/circj.CJ-11-1133 - In vivo measurement of aldehyde dehydrogenase-2 activity in rat liver ethanol model using dynamic MRSI of hyperpolarized [1-13C]pyruvate
- Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase Cδ (PKCδ) inhibits mitochondria elimination by lysosomal-like structures following ischemia and reoxygenation-induced injury
- Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein-protein interaction inhibitor reveals a non-catalytic role for GAPDH oligomerization in cell death
- Disruption of mitochondrial quality control in peripheral arterydisease: new therapeutic opportunities
- Mitochondrial dysfunction in degenerative diseases
- Participação da isoforma proteína quinase C 'beta' II na insuficiência cardíaca
- New therapeutics to modulate mitochondrial dynamics and mitophagy in cardiac diseases
- Mitochondrial quality control in cardiac diseases
- Targeting mitochondrial dysfunction and oxidative stress in heart failure: challenges and opportunities
- Alcohol consumption and vascular disease: other points to consider
Informações sobre o DOI: 10.1253/circj.CJ-11-1133 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas